Plain-English translation of NCT03925662 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Colorectal Cancer research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing whether , a medication that's been used for other conditions, might help improve treatment outcomes when added to standard colon cancer therapy. Researchers want to see if this medication can work alongside the existing treatments (chemotherapy and a targeted therapy called Avastin) to help patients with advanced colorectal cancer.
Standard treatments for advanced colon cancer help many patients, but doctors are always looking for ways to improve outcomes. This study explores whether this medication might boost the effectiveness of current therapies.
You likely qualify if…
You likely don't qualify if…
You would receive either the standard colon cancer treatment alone, or the same treatment plus . The trial will compare how well each approach works for you. You'll likely have regular visits for treatment, blood tests, and scans to monitor your progress.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Egypt
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.